Bachir Ghandour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bachir Ghandour has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Mouen A. Khashab
Division of Gastroenterology and Hepatology, Johns Hopkins Medicine, Baltimore, USA
10 shared publicationsMichael Bejjani
Division of Gastroenterology and Hepatology, Johns Hopkins Medicine, Baltimore, USA
8 shared publicationsMatthew T. Huggett
Division of Gastroenterology and Hepatology, Leeds Teaching Hospitals NHS Trust, Leeds, Leeds, UK
5 shared publicationsRishi Pawa
Division of Gastroenterology and Hepatology, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA
5 shared publicationsThomas E. Kowalski
Division of Gastroenterology and Hepatology, Thomas Jefferson Hospital, Philadelphia, Pennsylvania, USA
5 shared publicationsBharat Paranandi
Division of Gastroenterology and Hepatology, Leeds Teaching Hospitals NHS Trust, Leeds, Leeds, UK
4 shared publications
Latest Publications
- 29 April 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (2) , 532-545
Waitlisting and liver transplantation for MetALD in the United States: An analysis of the UNOS national registry
Background and aims: The new steatotic liver disease (SLD) nomenclature introduced metabolic and alcohol-associated liver disease (MetALD), describing the intersection of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). Waitlisting and liver transplantation for MetALD are not well-defined. We aimed to develop and validate an algorithm for identifying SLD phenotypes and assess trends in waitlisting and transplant outcomes. Methods: We conducted a retrospective cohort study using the United Network for Organ Sharing registry, supplemented with detailed single-center data. We developed five candidate algorithms for SLD classification and calculated their diagnostic performance. Trends in waitlist registrations and transplants were estimated, and competing risk analyses and Cox regression models were conducted to assess waitlist removal and post-transplant outcomes among SLD phenotypes. Results: The best-performing algorithm demonstrated substantial agreement (weighted kappa, 0.62) for SLD phenotypes, with acceptable sensitivity (73%) for MetALD. Between 2002-2022, waitlist registrations and transplants for MetALD increased 2.9-fold and 3.3-fold. Since 2013, there was a significant increase in the absolute number of waitlist registrations (122 per year; 95% CI, 111-133) and transplants (107 per year; 95% CI, 94-120) for MetALD. Patients with MetALD experienced higher waitlist removal (aSHR, 1.10; 95% CI, 1.03-1.17), all-cause mortality (aHR, 1.13; 95%, 1.03-1.23), and graft failure (aHR, 1.12; 95% CI, 1.03-1.21) than those with ALD. Conclusions: We developed and validated an algorithm for identifying SLD phenotypes in UNOS. MetALD is the third leading etiology among those waitlisted and transplanted, exhibiting worse pre- and post-transplantation outcomes compared to ALD. Identifying and addressing factors determining poor outcomes is crucial in this patient population. Export
- 29 April 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (2) , 532-545
Waitlisting and liver transplantation for MetALD in the United States: An analysis of the UNOS national registry
Background and aims: The new steatotic liver disease (SLD) nomenclature introduced metabolic and alcohol-associated liver disease (MetALD), describing the intersection of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). Waitlisting and liver transplantation for MetALD are not well-defined. We aimed to develop and validate an algorithm for identifying SLD phenotypes and assess trends in waitlisting and transplant outcomes. Methods: We conducted a retrospective cohort study using the United Network for Organ Sharing registry, supplemented with detailed single-center data. We developed five candidate algorithms for SLD classification and calculated their diagnostic performance. Trends in waitlist registrations and transplants were estimated, and competing risk analyses and Cox regression models were conducted to assess waitlist removal and post-transplant outcomes among SLD phenotypes. Results: The best-performing algorithm demonstrated substantial agreement (weighted kappa, 0.62) for SLD phenotypes, with acceptable sensitivity (73%) for MetALD. Between 2002-2022, waitlist registrations and transplants for MetALD increased 2.9-fold and 3.3-fold. Since 2013, there was a significant increase in the absolute number of waitlist registrations (122 per year; 95% CI, 111-133) and transplants (107 per year; 95% CI, 94-120) for MetALD. Patients with MetALD experienced higher waitlist removal (aSHR, 1.10; 95% CI, 1.03-1.17), all-cause mortality (aHR, 1.13; 95%, 1.03-1.23), and graft failure (aHR, 1.12; 95% CI, 1.03-1.21) than those with ALD. Conclusions: We developed and validated an algorithm for identifying SLD phenotypes in UNOS. MetALD is the third leading etiology among those waitlisted and transplanted, exhibiting worse pre- and post-transplantation outcomes compared to ALD. Identifying and addressing factors determining poor outcomes is crucial in this patient population. Export
- 26 January 2023
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 42 (1) , 118-127
Effective, safe and efficient porcine model of Forrest Ib bleeding gastric and colonic ulcers
Background Developing effective gastrointestinal (GI) bleeding animal models is necessary to advance endoscopic hemostasis methods and train endoscopists on their use. Our aim, therefore, was to develop an effective and safe porcine GI bleeding model in the stomach and colon of large and small-sized oozing-type ulcers. Methods Gastric and colonic bleeding ulcers were created using either a hybrid endoscopic submucosal dissection (ESD) technique or a cap-assisted endoscopic mucosal resection (EMR-C) technique in 14 pigs. Prior to ulcer creation, animals were treated with either oral apixaban or intravenous (IV) unfractionated heparin anticoagulation in combination with clopidogrel and aspirin. The primary outcome was the technical success of inducing oozing-type Forrest Ib bleeding ulcers. Secondary outcomes included ulcer diameter, number, creation time and the number of complications associated with each technique. Results Using hybrid ESD and IV heparin anticoagulation, bleeding was observed in 21/23 (91.3%) gastric ulcers and 6/7 (85.7%) colonic ulcers created. The mean diameter and ulcer creation time were 2.3 ± 0.3 cm and 5.3 ± 0.5 min, respectively, for gastric ulcers and 2.2 ± 0.4 cm and 4.06 ± 0.6 min, respectively, for colonic ulcers. Using EMR-C and IV heparin anticoagulation, bleeding was observed in 14/15 (93.3%) gastric ulcers and 6/6 (100%) colonic ulcers created. The mean diameter and ulcer creation time were 0.8 ± 0.2 cm and 2.1 ± 0.5 min, respectively, for gastric ulcers and 0.7 ± 0.2 cm and 1.7 ± 0.3 min, respectively, for colonic ulcers. None of the ulcers created in animals anticoagulated with apixaban developed bleeding. None of the 14 pigs developed any complications. Conclusion We have demonstrated the effectiveness and safety of a porcine GI bleeding model utilizing IV heparin anticoagulation and either hybrid ESD or EMR-C techniques to create oozing-type bleeding ulcers in the stomach and colon with customizable size.
- 26 January 2023
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 42 (1) , 118-127
Effective, safe and efficient porcine model of Forrest Ib bleeding gastric and colonic ulcers
Background Developing effective gastrointestinal (GI) bleeding animal models is necessary to advance endoscopic hemostasis methods and train endoscopists on their use. Our aim, therefore, was to develop an effective and safe porcine GI bleeding model in the stomach and colon of large and small-sized oozing-type ulcers. Methods Gastric and colonic bleeding ulcers were created using either a hybrid endoscopic submucosal dissection (ESD) technique or a cap-assisted endoscopic mucosal resection (EMR-C) technique in 14 pigs. Prior to ulcer creation, animals were treated with either oral apixaban or intravenous (IV) unfractionated heparin anticoagulation in combination with clopidogrel and aspirin. The primary outcome was the technical success of inducing oozing-type Forrest Ib bleeding ulcers. Secondary outcomes included ulcer diameter, number, creation time and the number of complications associated with each technique. Results Using hybrid ESD and IV heparin anticoagulation, bleeding was observed in 21/23 (91.3%) gastric ulcers and 6/7 (85.7%) colonic ulcers created. The mean diameter and ulcer creation time were 2.3 ± 0.3 cm and 5.3 ± 0.5 min, respectively, for gastric ulcers and 2.2 ± 0.4 cm and 4.06 ± 0.6 min, respectively, for colonic ulcers. Using EMR-C and IV heparin anticoagulation, bleeding was observed in 14/15 (93.3%) gastric ulcers and 6/6 (100%) colonic ulcers created. The mean diameter and ulcer creation time were 0.8 ± 0.2 cm and 2.1 ± 0.5 min, respectively, for gastric ulcers and 0.7 ± 0.2 cm and 1.7 ± 0.3 min, respectively, for colonic ulcers. None of the ulcers created in animals anticoagulated with apixaban developed bleeding. None of the 14 pigs developed any complications. Conclusion We have demonstrated the effectiveness and safety of a porcine GI bleeding model utilizing IV heparin anticoagulation and either hybrid ESD or EMR-C techniques to create oozing-type bleeding ulcers in the stomach and colon with customizable size.
- 10 October 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (2) , 260-267
Factors predictive of persistent fistulas in EUS-directed transgastric ERCP: a multicenter matched case-control study
- 10 October 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (2) , 260-267
Factors predictive of persistent fistulas in EUS-directed transgastric ERCP: a multicenter matched case-control study
- 4 August 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (02) , 186-191
Through-the-scope suture closure of peroral endoscopic myotomy mucosal incision sites
Background Peroral endoscopic myotomy (POEM) is now widely used for esophageal motility disorders including achalasia. Closure of the mucosal incision site is a critical step of the procedure. We evaluated the use of a novel through-the-scope (TTS) suture system for closure of POEM mucosal incision sites. Methods We retrospectively reviewed consecutive patients who underwent POEM with TTS suture closure at our institution between February and July 2021. Technical success was defined as complete mucosal incision site closure using TTS suturing, without the need for adjunctive devices. Continuous variables are presented as median (interquartile range [IQR]) or mean (SD). Results 35 consecutive patients (median age 58 years [IQR 46.5–72]; 54.3 % female) underwent POEM with attempted mucosal closure by TTS suturing. Technical success was achieved in 32 patients (91.4 %) with a mean closure time of 12.4 (SD 6.9) minutes. The median mucosal incision length at time of closure was 2.5 cm (IQR 2–2.5). Overall, 17 patients (53.1 %) required ≥ 2 TTS suture systems and 3 patients (8.6 %) required additional TTS clips to achieve secure mucosal closure. No adverse events were encountered. Conclusions TTS suturing was effective and safe for POEM mucosotomy closure. However, prospective comparative trials and cost-effectiveness analyses are warranted before routine adoption.
- 4 August 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (02) , 186-191
Through-the-scope suture closure of peroral endoscopic myotomy mucosal incision sites
Background Peroral endoscopic myotomy (POEM) is now widely used for esophageal motility disorders including achalasia. Closure of the mucosal incision site is a critical step of the procedure. We evaluated the use of a novel through-the-scope (TTS) suture system for closure of POEM mucosal incision sites. Methods We retrospectively reviewed consecutive patients who underwent POEM with TTS suture closure at our institution between February and July 2021. Technical success was defined as complete mucosal incision site closure using TTS suturing, without the need for adjunctive devices. Continuous variables are presented as median (interquartile range [IQR]) or mean (SD). Results 35 consecutive patients (median age 58 years [IQR 46.5–72]; 54.3 % female) underwent POEM with attempted mucosal closure by TTS suturing. Technical success was achieved in 32 patients (91.4 %) with a mean closure time of 12.4 (SD 6.9) minutes. The median mucosal incision length at time of closure was 2.5 cm (IQR 2–2.5). Overall, 17 patients (53.1 %) required ≥ 2 TTS suture systems and 3 patients (8.6 %) required additional TTS clips to achieve secure mucosal closure. No adverse events were encountered. Conclusions TTS suturing was effective and safe for POEM mucosotomy closure. However, prospective comparative trials and cost-effectiveness analyses are warranted before routine adoption.
- 25 May 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 96 (4) , 630-638
EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy: a multicenter experience
- 25 May 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 96 (4) , 630-638
EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy: a multicenter experience
- Open Access
EUS-directed transgastric ERCP in Roux-en-Y gastric bypass revision of sleeve gastrectomy
- 16 May 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 95 (6) , 1283-1284
Generalizability challenges of a machine learning model for classification of indeterminate biliary strictures
- 16 May 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 95 (6) , 1283-1284
Generalizability challenges of a machine learning model for classification of indeterminate biliary strictures
- 16 March 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , C10
Correction: Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs. 15-mm lumen-apposing metal stents
Publication Date: 16 March 2022 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 16 March 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , C10
Correction: Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs. 15-mm lumen-apposing metal stents
Publication Date: 16 March 2022 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Top Cited Papers
- 1 January 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 95 (1) , 80-89
Classification, outcomes, and management of misdeployed stents during EUS-guided gastroenterostomy
- 1 January 2022
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 95 (1) , 80-89
Top Cited PapersClassification, outcomes, and management of misdeployed stents during EUS-guided gastroenterostomy
- 14 December 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , 706-711
Novel 15-mm-long lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic fluid collections located ≥10 mm from the luminal wall
Background Endoscopic ultrasound (EUS)-guided drainage of pancreatic fluid collections (PFCs) by cautery-enhanced lumen-apposing metal stents (LAMS) has largely been limited to collections located < 10 mm from the luminal wall. We present outcomes of the use of a novel 15-mm-long cautery-enhanced LAMS for drainage of PFCs located ≥ 10 mm away. Methods This international, multicenter study analyzed all adults with PFCs located ≥ 10 mm from the luminal wall who were treated by EUS-guided drainage using the 15-mm-long cautery-enhanced LAMS. The primary outcome was technical success. Secondary outcomes included clinical success (decrease in PFC size by ≥ 50 % at 30 days and resolution of clinical symptoms without surgical intervention), complications, and recurrence. Results 35 patients (median age 57 years; interquartile range [IQR] 47–64 years; 49 % male) underwent novel LAMS placement for drainage of PFCs (26 walled-off necrosis, 9 pseudocysts), measuring 85 mm (IQR 64–117) maximal diameter and located 11.8 mm (IQR 10–12.3; range 10–14) from the gastric/duodenal wall. Technical and clinical success were high (both 97 %), with recurrence in one patient (3 %) at a median follow-up of 123 days (58–236). Three complications occurred (9 %; one mild, two moderate). Conclusions The 15-mm-long cautery-enhanced LAMS was feasible and safe for drainage of PFCs located 10–14 mm from the luminal wall.
- 14 December 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , 706-711
Novel 15-mm-long lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic fluid collections located ≥10 mm from the luminal wall
Background Endoscopic ultrasound (EUS)-guided drainage of pancreatic fluid collections (PFCs) by cautery-enhanced lumen-apposing metal stents (LAMS) has largely been limited to collections located < 10 mm from the luminal wall. We present outcomes of the use of a novel 15-mm-long cautery-enhanced LAMS for drainage of PFCs located ≥ 10 mm away. Methods This international, multicenter study analyzed all adults with PFCs located ≥ 10 mm from the luminal wall who were treated by EUS-guided drainage using the 15-mm-long cautery-enhanced LAMS. The primary outcome was technical success. Secondary outcomes included clinical success (decrease in PFC size by ≥ 50 % at 30 days and resolution of clinical symptoms without surgical intervention), complications, and recurrence. Results 35 patients (median age 57 years; interquartile range [IQR] 47–64 years; 49 % male) underwent novel LAMS placement for drainage of PFCs (26 walled-off necrosis, 9 pseudocysts), measuring 85 mm (IQR 64–117) maximal diameter and located 11.8 mm (IQR 10–12.3; range 10–14) from the gastric/duodenal wall. Technical and clinical success were high (both 97 %), with recurrence in one patient (3 %) at a median follow-up of 123 days (58–236). Three complications occurred (9 %; one mild, two moderate). Conclusions The 15-mm-long cautery-enhanced LAMS was feasible and safe for drainage of PFCs located 10–14 mm from the luminal wall.